2022 Symposium on Sickle Cell Disease

Friday, November 11, 2022, 8:00 AM - 3:40 PM, Nationwide Children's Hospital Conference Center


AMA PRA Category 1 Credits™ (5.50 hours), ANCC Contact Hour(s) (5.50 hours), APA Credit(s) (5.50 hours), ASWB ACE Credit(s) (5.50 hours), Non-Physician Attendance (5.50 hours)

This symposium will provide information to our regional colleagues and our patients and families on current clinical trials and advances in the field of Disease Modifying Therapies (DMT), Stem Cell Transplantation (SCT) and Gene Therapy in Sickle Cell Disease (SCD). The aim of this symposium is to critically analyze and review the pros and cons of these newer treatments including curative options.

1. Review current and upcoming disease modifying drugs for SCD such as crizanlizumab, voxelotor, glutamine and others that are in the pipeline.
2. Compare the different alternative donor (non-sibling) choices for HCT in SCD and recent developments in matched sibling donor transplant for SCD
3. Discuss the advances in gene therapy for SCD
4. Analyze the long-term effects of all available therapies including curative options; review current data on risk for malignancies and infertility in patient with SCD

In support of improving patient care, Nationwide Children's Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center (ANCC),  and the Accreditation Council for Pharmacy Education (ACPE), to provide continuing medical education for the healthcare team.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Nationwide Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Nationwide Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The Nationwide Children's Hospital® adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Nationwide Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 11, 2022

Exhibit at this Event